Hugo Chapdelaine

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich et al. · Journal of Allergy and Clinical Immunology · 2018 · 423 citations · Full text

Clinical Immunology, Allergy, Lymphocyte Development +12

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 246 citations · Full text

Therapeutic options for CTLA-4 insufficiency

David Egg, Ina Caroline Rump, Noriko Mitsuiki et al. · Journal of Allergy and Clinical Immunology · 2021 · 114 citations · Full text

Translational Medicine, Ctla-4 Insufficiency, Autoimmune Disease +8

Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: A retrospective case series

Nicolas Noël, Nizar Mahlaoui, Stéphane Blanche et al. · Journal of Allergy and Clinical Immunology · 2013 · 31 citations

Rheumatology, Chronic Granulomatous Disease, Granulocyte +6

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Karyne Pelletier, Arnaud Bonnefoy, Hugo Chapdelaine et al. · Kidney International Reports · 2019 · 30 citations · Full text